✦ LIBER ✦

Chemotherapy and Targeted Therapy for Women With Human Epidermal Growth Factor Receptor 2-Negative (or unknown) Advanced Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

✍ Scribed by Partridge, A. H.; Rumble, R. B.; Carey, L. A.; Come, S. E.; Davidson, N. E.; Di Leo, A.; Gralow, J.; Hortobagyi, G. N.; Moy, B.; Yee, D.; Brundage, S. B.; Danso, M. A.; Wilcox, M.; Smith, I. E.

Book ID: 126180084
Publisher: American Society of Clinical Oncology
Year: 2014
Tongue: English
Weight: 192 KB
Volume: 32
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2014.56.7479

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recommendations on Disease Management fo

Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: American Society of Clinical Oncology Clinical Practice Guideline

✍ Ramakrishna, N.; Temin, S.; Chandarlapaty, S.; Crews, J. R.; Davidson, N. E.; Es 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 114 KB

American Society of Clinical Oncology/Co

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

✍ Wolff, A. C.; Hammond, M. E. H.; Schwartz, J. N.; Hagerty, K. L.; Allred, D. C.; 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 279 KB

Estrogen Receptor and Receptor Tyrosine

Estrogen Receptor and Receptor Tyrosine Kinase Signaling: Use of Combinatorial Hormone and Epidermal Growth Factor Receptor/Human Epidermal Growth Factor Receptor 2-Targeted Therapies for Breast Cancer

✍ Zabransky, D. J.; Park, B. H. 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 233 KB

Phase IIa Trial of Trastuzumab Emtansine

Phase IIa Trial of Trastuzumab Emtansine With Pertuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive, Locally Advanced, or Metastatic Breast Cancer

✍ Miller, K. D.; Dieras, V.; Harbeck, N.; Andre, F.; Mahtani, R. L.; Gianni, L.; A 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 148 KB

RIBBON-1: Randomized, Double-Blind, Plac

RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative, Locally Recurrent or Metastatic Breast Cancer

✍ Robert, N. J.; Dieras, V.; Glaspy, J.; Brufsky, A. M.; Bondarenko, I.; Lipatov, 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 317 KB

Effect of Age on Breast Cancer Outcomes

Effect of Age on Breast Cancer Outcomes in Women With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From a Herceptin Adjuvant Trial

✍ Partridge, A. H.; Gelber, S.; Piccart-Gebhart, M. J.; Focant, F.; Scullion, M.; 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 157 KB